[{"address1": "131 Dartmouth Street", "address2": "3rd Floor", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "650 503 9095", "website": "https://www.adicetbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. The company is also developing ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma for treating other CD70+ solid tumor and hematological malignancies indications. The company was founded in 2014 and is based in Boston, Massachusetts.", "fullTimeEmployees": 143, "companyOfficers": [{"maxAge": 1, "name": "Mr. Chen  Schor BA, CPA, M.B.A.", "age": 51, "title": "CEO, President & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 871968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Aya  Jakobovits Ph.D.", "age": 68, "title": "Founder & Independent Director", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian Nicholas Harvey", "age": 62, "title": "Chief Financial Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 594938, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Donald  Healey Ph.D.", "age": 61, "title": "Chief Technology Officer", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 606337, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Blake  Aftab Ph.D.", "age": 42, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 675039, "exercisedValue": 0, "unexercisedValue": 22015}, {"maxAge": 1, "name": "Ms. Amy  Locke", "title": "Chief Human Resource Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francesco  Galimi M.D., Ph.D.", "age": 55, "title": "Chief Medical Officer & Senior VP", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 680365, "exercisedValue": 0, "unexercisedValue": 266029}, {"maxAge": 1, "name": "Dr. Nancy L. Boman M.D., Ph.D.", "title": "Senior VP & Chief Regulatory Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.51, "open": 1.52, "dayLow": 1.44, "dayHigh": 1.54, "regularMarketPreviousClose": 1.51, "regularMarketOpen": 1.52, "regularMarketDayLow": 1.44, "regularMarketDayHigh": 1.54, "beta": 1.686, "forwardPE": -0.94736844, "volume": 318171, "regularMarketVolume": 318171, "averageVolume": 952167, "averageVolume10days": 371870, "averageDailyVolume10Day": 371870, "bid": 1.43, "ask": 1.46, "bidSize": 400, "askSize": 200, "marketCap": 118657448, "fiftyTwoWeekLow": 1.05, "fiftyTwoWeekHigh": 3.77, "fiftyDayAverage": 1.3736, "twoHundredDayAverage": 1.840075, "currency": "USD", "enterpriseValue": -80511552, "floatShares": 53881164, "sharesOutstanding": 82401000, "sharesShort": 4573889, "sharesShortPriorMonth": 5338197, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0555, "heldPercentInsiders": 0.01591, "heldPercentInstitutions": 0.78407997, "shortRatio": 4.97, "shortPercentOfFloat": 0.0657, "impliedSharesOutstanding": 82401000, "bookValue": 2.853, "priceToBook": 0.5047319, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -137291008, "trailingEps": -2.52, "forwardEps": -1.52, "pegRatio": -0.04, "lastSplitFactor": "1:7", "lastSplitDate": 1600214400, "enterpriseToEbitda": 0.663, "52WeekChange": -0.15168542, "SandP52WeekChange": 0.24014747, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ACET", "underlyingSymbol": "ACET", "shortName": "Adicet Bio, Inc.", "longName": "Adicet Bio, Inc.", "firstTradeDateEpochUtc": 1516977000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "65920c5d-73a6-39e2-8917-c1ab3dd20f9e", "messageBoardId": "finmb_310073311", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.44, "targetHighPrice": 19.0, "targetLowPrice": 5.0, "targetMeanPrice": 9.0, "targetMedianPrice": 7.0, "recommendationMean": 1.9, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 224068992, "totalCashPerShare": 2.719, "ebitda": -121497000, "totalDebt": 19132000, "quickRatio": 12.515, "currentRatio": 12.754, "debtToEquity": 8.137, "returnOnAssets": -0.29298002, "returnOnEquity": -0.57908, "freeCashflow": -55261000, "operatingCashflow": -90995000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]